Rulemaking For OTC Switch Process Changes Pushed To 2019
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Target date moved from August 2018 to February 2019 for publishing an NPRM for allowing currently Rx drug ingredients to be available nonprescription under conditions of safe use. US HHS annual spring update on regulatory priorities for FDA and its other agencies also pushes back target dates for other OTC drug NPRMs, including FDA's long-delayed finalization of several monographs including sunscreen ingredients.
You may also be interested in...
OTC Monograph Bill Has Energy And Commerce Date, CDER Director's Hope
US House is catching up with Senate on OTC monograph legislation, with a committee markup expected in the next few days.
HHS Regulatory Agenda Omits Drug Pricing Actions – Unless OTC Switches Still Count
HHS’ 'statement of regulatory priorities' for 2018 does not even offer lip service to idea of addressing Rx costs. It does, however, suggest plans to move forward with an effort to increase OTC switches – which was an Obama era idea to lower drug costs.